Policy & Regulation
Profusa launches Lumee tissue oxygen system for CRO market
16 January 2026 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, announced on Friday the launch of a h...
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
16 January 2026 - China-based medical technology company Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) said on Friday that it has entered into a definitive agreement to acquire Germany-bas...
European Commission approves Sobi's Aspaveli for rare kidney diseases
16 January 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI) said on Friday that the European Commission has approved Aspaveli (pegcetacoplan) for use in adults and adolescents aged 12 to 17 w...
Frontage Laboratories commences GMP facility operations
16 January 2026 - Frontage Laboratories Inc, a US-based contract development and manufacturing organisation (CDMO) and subsidiary of Frontage Holdings Corporation (HKEX:1521), announced on Thursday th...
Myqorzo and Redemplo receive regulatory approval in China
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licen...
AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab
15 January 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzu...